Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[High doses statins administration causing rhabdomyolysis: case report].

Mirnaluci P Ribeiro Gama1, Silviane Pellegrinello, Sheyla Santos Quelle Alonso

  • 1Departamento de Medicina Interna, Faculdade Evangélica do Paraná, Hospital Universitário Evangélico de Curitiba, Curitiba, RS. m.gama@sul.com.br

Arquivos Brasileiros De Endocrinologia E Metabologia
|December 17, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wnt3a but not CDX-2 expression is associated with differentiated thyroid cancer.

Revista da Associacao Medica Brasileira (1992)·2022
Same author

[Not Available].

Revista brasileira de hematologia e hemoterapia·2014
Same author

Vitamin D deficiency in children and adolescents submitted to hematopoietic stem cell transplantation.

Revista brasileira de hematologia e hemoterapia·2014
Same author

[Oncogenic osteomalacia: localization of underlying peripheral tumor with 99mTc-sestamibi scintigraphy].

Arquivos brasileiros de endocrinologia e metabologia·2009

Statin-associated rhabdomyolysis can be fatal, especially when combined with other medications. This case highlights a fatal instance in a patient with diffuse atherosclerotic disease.

Area of Science:

  • Cardiology
  • Pharmacology
  • Toxicology

Background:

  • Rhabdomyolysis is a serious medical condition with a long history in medical literature.
  • Statins are widely prescribed for cardiovascular prevention, leading to increased focus on their side effects.
  • Drug interactions are a significant factor in the occurrence of statin-induced rhabdomyolysis.

Observation:

  • This report details a case of a patient who developed fatal rhabdomyolysis.
  • The patient had a history of diffuse atherosclerotic disease.
  • Statin administration was identified as the trigger for the rhabdomyolysis.

Findings:

  • Fatal statin-induced rhabdomyolysis occurred in this patient.
  • The patient's underlying diffuse atherosclerotic disease may have contributed to the outcome.

Related Experiment Videos

  • Concurrent medication use, common in statin therapy, is often implicated in such cases.

    • Implications:

    • This case underscores the critical risk of statin-induced rhabdomyolysis, particularly in patients with comorbidities.
    • Awareness of potential drug interactions is crucial for clinicians managing patients on statin therapy.
    • Further research into risk factors and preventative strategies for statin-induced rhabdomyolysis is warranted.